Dr. Clement Chikai Chow, MD

Dr. Chow practices at Retinal Diagnostic Center a Medical Corporation in Campbell, California.

Dr. Chow's NPI, 1265606461, was assigned on April 17, 2008. Dr. Chow graduated from University of Wisconsin-Madison in 2007. Dr. Chow holds California license A126226.

Dr. Chow's primary practice is Retinal Diagnostic Center a Medical Corporation, at 3395 S Bascom Ave, Campbell, CA 95008 in Santa Clara County. The practice phone is (408) 559-0666.

Dr. Chow's primary practice is Retinal Diagnostic Center a Medical Corporation in Campbell, California. Dmand AI also links Dr. Chow to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chow practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chow's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chow is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chow's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Chow treats.

CMS data shows 106,721 Medicare services from Dr. Chow across 18 procedure codes in 2024, for 1,302 Medicare patients. Medicare paid $4,209,183 for them.

CMS counts 1,302 Medicare patients who saw Dr. Chow in 2024. The largest group is 65 to 74, with 500 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chow's median patient age at 71, with 49% women.

In 2024, Dr. Chow wrote 532 Medicare Part D claims for 139 patients. 67% of them were for generic drugs. CMS names the drug for 474 of them, across 11 drugs with 11 or more claims each, at $13,520 in total drug cost. In 2023, CMS named 533 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chow for performance year 2024, reported as part of a group. Dr. Chow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of cataract surgery by Dr. Chow, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 27 papers to Dr. Chow, published from 2007 to 2021. 2013 was the busiest year, with 4. The most frequent topics are Visual Acuity, Retinal Diseases and Intravitreal Injections. Dr. Chow has published most often in Am J Ophthalmol. Dr. Chow's most frequent co-authors are Michael Pr Blair, FNP-C, Felix Yan-Fay Chau, MD and William F. Mieler, MD.

CMS Open Payments shows 198 general payments to Dr. Chow from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Genentech, Inc. paid the most, $1,884.

Dr. Chow graduated from University of Wisconsin-Madison in 2007. Dr. Chow is a member of AOA, AAO, AMA and ASRS.

Dr. Chow is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.